Athan, E., Chu, V. H., Tattevin, P., Selton-Suty, C., Jones, P., Naber, C., … Wang, A. (2013). SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES. In International Journal of Antimicrobial Agents (Vol. 41, pp. S3–S3). Elsevier BV. https://doi.org/10.1016/s0924-8579(13)70010-4

Athan, E., V. H. Chu, P. Tattevin, C. Selton-Suty, P. Jones, C. Naber, J. M. Miró, et al. “SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES.” In International Journal of Antimicrobial Agents, 41:S3–S3. Elsevier BV, 2013. https://doi.org/10.1016/s0924-8579(13)70010-4.

Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES. In: International Journal of Antimicrobial Agents. Elsevier BV; 2013. p. S3–S3.

Athan, E., et al. “SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES.” International Journal of Antimicrobial Agents, vol. 41, Elsevier BV, 2013, pp. S3–S3. Crossref, doi:10.1016/s0924-8579(13)70010-4.

Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-Mangoni E, Spelman D, Hoen B, Zupanc TL, Cecchi E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG, Crowley AL, Wang A. SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES. International Journal of Antimicrobial Agents. Elsevier BV; 2013. p. S3–S3.